ArticleBMC infectious diseases2022

Prevalence of SARS-Cov-2 antibodies and living conditions: the French national random population-based EPICOV cohort.

Josiane Warszawski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.